Opendata, web and dolomites

NanoMop SIGNED

Smart Cholesterol-Mopping Polymer Nanoparticles in Niemann-Pick Disease Type C

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NanoMop project word cloud

Explore the words cloud of the NanoMop project. It provides you a very rough idea of what is the project "NanoMop" about.

capacity    progress    caused    recognised    stakeholders    chemistry    horizon2020    me    decline    class    question    successfully    bcds    life    profile    incidence    excellent    researcher    pharmacokinetics    childhood    area    cds    overcome    brain    niemann    chemical    academic    personally    answered    bioavailability    edge    people    biological    cholesterol    cognitive    networking    naturally    international    intervention    pick    interdisciplinary    training    complications    techniques    diversify    carry    skillset    disease    subsequent    inter    completion    urgently    nanoparticles    bcd    occurring    gained    mobility    family    macromolecular    successful    smart    decade    disorder    poor    accumulation    charity    alzheimer    genetic    sequester    create    treatment    industrial    competences    therapeutic    designed    polymer    detected    line    modification    players    significantly    therapies    limitations    cyclodextrins    reaching    cutting    considerable    nanomops    sugars    npc    fellowship    pursue    sectoral    puts    suffers    professionally    broaden    threatening    career    rare    independent    internationally    health    position   

Project "NanoMop" data sheet

The following table provides information about the project.

Coordinator
ISTANBUL TEKNIK UNIVERSITESI 

Organization address
address: AYAZAGA KAMPUSU
city: MASLAK ISTANBUL
postcode: 34469
website: www.itu.edu.tr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Turkey [TR]
 Total cost 145˙845 €
 EC max contribution 145˙845 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-04-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ISTANBUL TEKNIK UNIVERSITESI TR (MASLAK ISTANBUL) coordinator 145˙845.00

Map

 Project objective

Niemann-Pick Disease Type C (NPC), also known as “childhood Alzheimer’s”, is a rare genetic disorder caused by the accumulation of cholesterol particularly in the brain with subsequent cognitive and mobility decline. In the EU NPC has an incidence of 1 per 100,000 people. Most cases are detected during childhood and progress to cause life-threatening complications by the second or third decade of life. Cyclodextrins (CDs), a family of naturally occurring sugars, have recently gained considerable attention as a potential therapeutic intervention in the treatment of the disease because of their capacity to sequester cholesterol. Although promising, the current treatment of NPC based on a chemical modification of bCD suffers from poor pharmacokinetics and bioavailability in the brain. In this project I propose a new interdisciplinary approach in which bCDs will be embedded into a novel class of smart polymer nanoparticles (NanoMops) that could overcome these limitations. The project addresses an important question that needs to be answered urgently and its successful completion will contribute to the treatment of the neglected disease in line with the Horizon2020 health goal of providing better and more effective therapies. My specific skillset in chemical modification of CDs puts me in a unique position to successfully carry out this project. This interdisciplinary proposal is designed to provide me with advanced training in macromolecular chemistry and in a range of cutting-edge biological techniques. The fellowship will significantly diversify my competences and broaden my profile – professionally and personally - enabling me to pursue a career as an internationally recognised independent researcher. The project will also create new important international and inter-sectoral partnerships with excellent academic and industrial players while reaching out to charity organisations, raising awareness and networking researchers and key stakeholders in the area of NPC.

 Publications

year authors and title journal last update
List of publications.
2019 Antonino Puglisi, Ece Bayir, Suna Timur, Yusuf Yagci
pH-Responsive Polymersome Microparticles as Smart Cyclodextrin-Releasing Agents
published pages: 4001-4007, ISSN: 1525-7797, DOI: 10.1021/acs.biomac.9b01083
Biomacromolecules 20/10 2019-10-30
2019 Antonino Puglisi, Yusuf Yagci
Cyclodextrin-Based Macromolecular Systems as Cholesterol-Mopping Therapeutic Agents in Niemann-Pick Disease Type C
published pages: 1800557, ISSN: 1022-1336, DOI: 10.1002/marc.201800557
Macromolecular Rapid Communications 40/1 2019-09-26

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NANOMOP" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NANOMOP" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

5G-ACE (2019)

Beyond 5G: 3D Network Modelling for THz-based Ultra-Fast Small Cells

Read More  

MacMeninges (2019)

Control of Central Nervous Sytem inflammation by meningeal macrophages, and its impairment upon aging

Read More  

MemoryAggregates (2020)

Mechanism of Whi3 Aggregation and its Age-dependent Malfunction

Read More